<SEC-DOCUMENT>0001564590-20-038598.txt : 20200810
<SEC-HEADER>0001564590-20-038598.hdr.sgml : 20200810
<ACCEPTANCE-DATETIME>20200810072052
ACCESSION NUMBER:		0001564590-20-038598
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20200810
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200810
DATE AS OF CHANGE:		20200810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UroGen Pharma Ltd.
		CENTRAL INDEX KEY:			0001668243
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38079
		FILM NUMBER:		201087067

	BUSINESS ADDRESS:	
		STREET 1:		9 HA'TA'ASIYA ST
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4365007
		BUSINESS PHONE:		972 9 770 7601

	MAIL ADDRESS:	
		STREET 1:		9 HA'TA'ASIYA ST
		CITY:			RA'ANANA
		STATE:			L3
		ZIP:			4365007
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>urgn-8k_20200810.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-08-06T00:30:25.0593379+00:00 -->
<!-- Version            : 5.0.1.476 -->
<!-- Package ID         : 05e185b275f2409eaf0cd869d4d8b0c0 -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:urgn="http://www.urogen.com/20200810" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
urgn-8k_20200810.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001668243_20200810_20200810">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001668243_20200810_20200810">0001668243</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="urgn-20200810.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001668243_20200810_20200810">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001668243</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-08-10</xbrli:startDate>
					<xbrli:endDate>2020-08-10</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001668243_20200810_20200810">8-K</ix:nonNumeric> </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of the Securities Exchange Act of 1934</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001668243_20200810_20200810" format="ixt:datemonthdayyearen">August 10, 2020</ix:nonNumeric></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001668243_20200810_20200810">UROGEN PHARMA LTD.</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001668243_20200810_20200810" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0001668243_20200810_20200810">001-38079</ix:nonNumeric> </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001668243_20200810_20200810">98-1460746</ix:nonNumeric> </p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
<tr style="height:12pt;">
<td colspan="3" valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0001668243_20200810_20200810">400 Alexander Park Drive</ix:nonNumeric>,&#160;<ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0001668243_20200810_20200810">4<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup>&#160;Floor</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0001668243_20200810_20200810">Princeton</ix:nonNumeric>,&#160;<ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0001668243_20200810_20200810" format="ixt-sec:stateprovnameen">New Jersey</ix:nonNumeric></p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0001668243_20200810_20200810">08540</ix:nonNumeric></p></td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0001668243_20200810_20200810">+1 (646)</ix:nonNumeric> <ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0001668243_20200810_20200810">768-9780</ix:nonNumeric> </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.05%;width:99.95%;">
<tr>
<td valign="top" style="padding-left:0.25pt;padding-Right:0.25pt;padding-Top:0.25pt;padding-Bottom:0.25pt;width:4%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0001668243_20200810_20200810" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="middle" style="padding-left:0.25pt;padding-Right:0.25pt;padding-Top:0.25pt;padding-Bottom:0.25pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.05%;width:99.95%;">
<tr>
<td valign="top" style="padding-left:0.25pt;padding-Right:0.25pt;padding-Top:0.25pt;padding-Bottom:0.25pt;width:4%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0001668243_20200810_20200810" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="middle" style="padding-left:0.25pt;padding-Right:0.25pt;padding-Top:0.25pt;padding-Bottom:0.25pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.05%;width:99.95%;">
<tr>
<td valign="top" style="padding-left:0.25pt;padding-Right:0.25pt;padding-Top:0.25pt;padding-Bottom:0.25pt;width:4%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0001668243_20200810_20200810" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="middle" style="padding-left:0.25pt;padding-Right:0.25pt;padding-Top:0.25pt;padding-Bottom:0.25pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.05%;width:99.95%;">
<tr>
<td valign="top" style="padding-left:0.25pt;padding-Right:0.25pt;padding-Top:0.25pt;padding-Bottom:0.25pt;width:4%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001668243_20200810_20200810" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="middle" style="padding-left:0.25pt;padding-Right:0.25pt;padding-Top:0.25pt;padding-Bottom:0.25pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0.5pt;width:auto; border-bottom:solid 1pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:auto; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0.5pt;width:auto; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symbol(s)</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;width:auto; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0.5pt;width:auto; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">on which registered</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0001668243_20200810_20200810">Ordinary Shares, par value NIS0.01 per share</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0001668243_20200810_20200810">URGN</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0001668243_20200810_20200810" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001668243_20200810_20200810" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 2.02 Results of Operations and Financial Condition. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 10, 2020, UroGen Pharma Ltd. (the &#8220;Company&#8221;) announced its financial results for the quarter ended June 30, 2020 in the press release attached hereto as Exhibit 99.1 and incorporated herein by reference. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information in this Item 2.02, including the attached Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. </p>
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01 Financial Statements and Exhibits. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) </p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:92%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="2" valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit<br />Number </p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:2pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description </p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1 </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:2pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="urgn-ex991_6.htm"><span style="text-decoration:underline;">Press Release dated August 10, 2020.</span></a><span style="text-decoration:underline;"> </span></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104 </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:2pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document). </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:46%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: August 10, 2020 </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UROGEN PHARMA LTD. </p></td>
</tr>
<tr style="height:12pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:1pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By: </p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:1pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Peter Pfreundschuh </p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Peter Pfreundschuh </p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer </p></td>
</tr>
</table></div>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>urgn-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
urgn-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gavzukk22krh000001.jpg" title="" alt="" style="width:173px;height:62px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:14pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">UroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate Developments</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Received U.S. FDA Approval of <font style="font-style:normal;">Jelmyto</font><sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>, the First and Only Non-Surgical Treatment for Patients with Low-Grade Upper Tract Urothelial Cancer (LG-UTUC)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Successfully Commenced Launch of <font style="font-style:normal;">Jelmyto</font> on June 1<sup style="font-size:85%;line-height:120%;vertical-align:top">st</sup> as Planned; Initial Commercial Performance Demonstrates Strong Execution</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Announced Positive Complete Response and Durability Data of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC); On Track to Commence Pivotal Phase 3 Trial by Year End</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Conference Call and Webcast to be Held Today at 8:30 AM ET</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">PRINCETON, N.J.<font style="font-weight:normal;">, August 10, 2020 - UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced financial results for the second quarter ended June 30, 2020 and provided an overview of the Company&#8217;s recent developments.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;The second quarter of 2020 has proved to be the most transformational time for UroGen, marked by the U.S. Food and Drug Administration approval of <font style="font-style:italic;">Jelmyto</font> for patients with low-grade upper tract urothelial cancer and our successful transition to a commercial-stage company. Despite global challenges and uncertainty as a result of the ongoing COVID-19 pandemic, the innovative solutions developed by our team have led to strong launch execution; a testament to our commitment to advancing this important medicine for patients in need of better options,&#8221; said Liz Barrett, President and Chief Executive Officer of UroGen. &#8220;In addition to continuing our commercialization efforts of <font style="font-style:italic;">Jelmyto</font>, we are on track to start our planned Phase 3 pivotal study of UGN-102 in patients with low-grade intermediate risk non-muscle invasive bladder cancer by the end of this year.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Recent Highlights and Upcoming Milestones</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jelmyto<font style="font-style:italic;"> (mitomycin) for pyelocalyceal solution, formerly known as UGN-101, for adult patients with low-grade upper tract urothelial cancer (LG-UTUC)</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">On April 15, 2020, the U.S. FDA granted approval of </font><font style="font-style:italic;font-family:Arial;">Jelmyto</font><font style="font-family:Arial;"> for the treatment of adult patients with LG-UTUC. </font><font style="font-style:italic;font-family:Arial;">Jelmyto</font><font style="font-family:Arial;"> is the first and only FDA approved non-surgical treatment option for patients with LG-UTUC.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">UroGen successfully commenced the commercial launch of </font><font style="font-style:italic;font-family:Arial;">Jelmyto</font><font style="font-family:Arial;"> on June 1, 2020.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">The commercial team continues to utilize innovative solutions, such as its virtual platform, to effectively engage health care professionals and patients in this unprecedented environment.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">To date, approximately 100 sites have been activated, which means they have completed their internal processes and have treated or are ready to treat patients.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-top:0pt;margin-bottom:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">Multiple treatments have been successfully reimbursed &#8211; both in the hospital and community setting &#8211; and the Company has submitted both our C-Code and J-Code applications and continues to expect receipt of a C-Code by October 2020 and a J-Code in January 2021.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">UGN-102 (mitomycin) for intravesical solution for patients with low-grade intermediate risk non-muscle invasive bladder cancer (LG-IR-NMIBC)</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></font><font style="font-family:Arial;">UroGen</font><font style="font-family:Arial;"> announced </font><font style="font-family:Arial;">the presentation of positive interim data from the </font><font style="font-family:Arial;">investigational agent </font><font style="font-family:Arial;">UGN-102 </font><font style="font-family:Arial;">Phase 2b OPTIMA II trial</font><font style="font-family:Arial;"> </font><font style="font-family:Arial;">in patients with</font><font style="font-family:Arial;"> </font><font style="font-family:Arial;">LG-IR-NMIBC</font><font style="font-family:Arial;">, which was accepted for </font><font style="font-family:Arial;">the 2020 AUA Annual Meeting, published as a supplement to the April 2020 issue of The Journal of Urology</font><font style="font-family:Arial;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup></font><font style="font-family:Arial;">,</font><font style="font-family:Arial;"> and presented as part of the AUA Virtual Experience</font><font style="font-family:Arial;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Courier New;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:Courier New;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:Courier New;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">o</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Courier New;font-size:10.5pt;"><font style="font-family:Arial;">The trial results demonstrated that 65% (41/63) of patients treated with UGN-102 achieved a complete response (CR) three months after the start of therapy. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Courier New;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:Courier New;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:Courier New;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">o</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Courier New;font-size:10.5pt;"><font style="font-family:Arial;">In this subset of patients, 97% (35/36) of patients (95% Confidence Interval), 86% (24/28) of patients and 85% (11/13) of patients who were present for evaluation at each timepoint, remained disease free at six, nine and 12 months following treatment initiation, respectively. Follow-up will continue until all patients have reached the 12-month time point.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Courier New;font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:Courier New;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:Courier New;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">o</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Courier New;font-size:10.5pt;"><font style="font-family:Arial;">The most common adverse events (&#8805; 10%) were reported as mild to moderate and include dysuria, hematuria, urinary frequency, fatigue, urgency and urinary tract infection.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">The Company remains on track to initiate a pivotal UGN-102 Phase 3 trial by year end.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">UGN-102 has the potential to provide a non-surgical treatment alternative for approximately 80,000 patients diagnosed with LG-IR-NMIBC in the United States.</font><font style="font-family:Calibri;font-size:11pt;"> </font><font style="font-family:Arial;">There are no drugs currently approved by the FDA as first-line treatment for LG-IR-NMIBC.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">UGN-302 (combination of UGN-201 and zalifrelimab) for patients with high-grade non muscle invasive bladder cancer (HG NMIBC)</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">UGN-302 is the combination of UGN-201, a TLR7/8 agonist, and zalifrelimab, an anti-CTLA-4 antibody, and is initially targeting HG NMIBC.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">Delivering the investigational combination intravesically has the potential to sidestep certain systemic side effects and adverse events associated with systemic CTLA-4 antibody administration.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-top:0pt;margin-bottom:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">In murine models, UGN-201, given sequentially with local anti-CTLA-4, increased survival.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Second Quarter 2020 Financial Results; 2020 Guidance</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">UroGen recorded net product sales of </font><font style="font-style:italic;font-family:Arial;">Jelmyto</font><font style="font-family:Arial;"> for the second quarter ended June 30, 2020 of approximately $371,500.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">As of June 30, 2020, cash, cash equivalents and marketable securities totaled $151.6 million, excluding restricted cash.</font><font style="font-family:Calibri;font-size:11pt;"> </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">Research and development expenses for the second quarter ended June 30, 2020 were $8.1 million, including non-cash share-based compensation expense of $1.6 million. This compares to $10.0 million, including non-cash share-based compensation expense of $2.0 million, for the same period in 2019. Research and development expenses for the six months ended June 30, 2020 were $24.7 million, including non-cash share-based compensation expense of $3.5 million. This compares to $19.7 million, including non-cash share-based compensation expense of $4.3 million, for the same period in 2019.&nbsp;&nbsp;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">Selling, general and administrative expenses for the second quarter ended June 30, 2020 were $24.0 million, including non-cash share-based compensation expense of $5.5 million. This compares to $13.8 million, including non-cash share-based compensation expense of $5.2 million, for the same period in 2019.</font><font style="font-family:Calibri;font-size:11pt;"> </font><font style="font-family:Arial;">Selling, general and administrative expenses for the six months ended June 30, 2020 were $46.0 million, including non-cash share-based compensation expense of $11.2 million. This compares to $26.5 million, including non-cash share-based compensation expense of $10.3 million, for the same period in 2019.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="font-family:Arial;">UroGen reported a net loss of $31.3 million, or basic and diluted net loss per ordinary share of $1.44, for the second quarter ended June 30, 2020. This compares to $22.5 million, or basic and diluted net loss per ordinary share of $1.08, for the same period in 2019. UroGen reported a net loss of $69.1 million, or basic and diluted net loss per ordinary share of $3.22, </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap"></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">for the six months ended June 30, </font><font style="font-family:Arial;">2020. This compares to $</font><font style="font-family:Arial;">43.9</font><font style="font-family:Arial;"> million, or basic and diluted net loss per ordinary share of $</font><font style="font-family:Arial;">2.19</font><font style="font-family:Arial;">, for the same period in 2019.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-top:0pt;margin-bottom:8pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-top:0pt;margin-bottom:8pt;font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;font-family:'Times New Roman';font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="margin-top:0pt;margin-bottom:8pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10.5pt;"><font style="font-family:Arial;">UroGen adjusted expense guidance down for 2020, driven by change in estimated non-cash share-based compensation expense for 2020. UroGen now expects 2020 total operating expenses in the range of $143 to $153 million, including non-cash share-based compensation expense of $30 to $34 million, subject to market conditions. No other changes have occurred regarding our previously provided guidance for 2020.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Conference Call &amp; Webcast Information</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Members of UroGen&#8217;s management team will host a live conference call and webcast today at 8:30&#160;AM Eastern Time to review the Company's financial results and provide a general business update.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The live webcast can be accessed by visiting the Investors section of the Company&#8217;s website at <font style="text-decoration:underline;">http://investors.urogen.com</font>. Please connect at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call (855) 765-5685 (U.S.) or (615) 247-5916 (International) to listen to the live conference call. The conference ID number for the live call will be 9168696. An archive of the webcast will be available for two weeks on the Company&#8217;s website.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:58.33%;"></td>
<td style="width:2.72%;"></td>
<td style="width:18.11%;"></td>
<td style="width:2.72%;"></td>
<td style="width:18.11%;"></td>
</tr>
<tr style="height:9pt;">
<td colspan="5" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UROGEN PHARMA LTD.</p></td>
</tr>
<tr style="height:9pt;">
<td colspan="5" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONDENSED CONSOLIDATED BALANCE SHEETS</p></td>
</tr>
<tr style="height:9pt;">
<td colspan="5" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(U.S. dollars in thousands, except share and per share data)</p></td>
</tr>
<tr style="height:9pt;">
<td colspan="5" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited)</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td>
</tr>
<tr style="height:9pt;">
<td colspan="5" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">CURRENT ASSETS:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36,350 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;49,688 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 88,773 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 97,389 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,224 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;523 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;402 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,125 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,069 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,034 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL CURRENT ASSETS</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 129,943 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 148,634 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NON-CURRENT ASSETS:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,401 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;977 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted deposit</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;223 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;223 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,011 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,735 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Marketable securities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26,499 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 48,555 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other non-current assets</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;264 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL ASSETS</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;161,077 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;202,388 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td colspan="5" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Liabilities and Shareholders' equity</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">CURRENT LIABILITIES:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:7pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,203 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11,186 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee related accrued expenses</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,744 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,711 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,476 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,585 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL CURRENT LIABILITIES</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16,423 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19,482 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NON-CURRENT LIABILITIES:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:7pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease liability</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,994 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,604 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL LIABILITIES</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18,417 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22,086 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL SHAREHOLDERS&#8217; EQUITY</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 142,660 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 180,302 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">TOTAL LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;161,077 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;202,388 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:35.69%;"></td>
<td style="width:14.05%;"></td>
<td style="width:2.7%;"></td>
<td style="width:14.05%;"></td>
<td style="width:2.7%;"></td>
<td style="width:14.05%;"></td>
<td style="width:2.7%;"></td>
<td style="width:14.05%;"></td>
</tr>
<tr>
<td style="width:35.69%;"></td>
<td style="width:14.05%;"></td>
<td style="width:2.7%;"></td>
<td style="width:14.05%;"></td>
<td style="width:2.7%;"></td>
<td style="width:14.05%;"></td>
<td style="width:2.7%;"></td>
<td style="width:14.05%;"></td>
</tr>
<tr style="height:9pt;">
<td colspan="8" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a><font style="font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UROGEN PHARMA LTD.</font></p></td>
</tr>
<tr style="height:9pt;">
<td colspan="8" valign="bottom"  BGCOLOR="#FFFFFF">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</p></td>
</tr>
<tr style="height:9pt;">
<td colspan="8" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(U.S. dollars in thousands, except share and per share data)</p></td>
</tr>
<tr style="height:9pt;">
<td colspan="8" valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited)</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Three months ended June 30,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="3" valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Six months ended June 30,</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">REVENUES</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;372 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;372 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">COST OF REVENUES</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 48 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8212; </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 48 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8212; </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">GROSS PROFIT</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 324 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 324 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">OPERATING EXPENSES:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:6.5pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8,106 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,996 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24,694 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19,722 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:6.5pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative expenses</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24,018 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13,775 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;45,991 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26,482 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">OPERATING LOSS</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (31,800)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (23,753)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (70,361)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (46,186)</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">INTEREST AND OTHER INCOME, NET</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 451 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,276 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,219 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,265 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NET LOSS</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(31,349)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(22,477)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(69,142)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(43,921)</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">STATEMENT OF COMPREHENSIVE LOSS</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NET LOSS</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(31,349)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(22,477)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(69,142)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(43,921)</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">OTHER COMPREHENSIVE INCOME:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">UNREALIZED GAIN ON MARKETABLE SECURITIES</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 449 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;281 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 484 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;281 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="middle"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">COMPREHENSIVE LOSS</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(30,900)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(22,196)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(68,658)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(43,640)</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">NET LOSS PER ORDINARY SHARE, BASIC AND DILUTED</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1.44)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1.08)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3.22)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2.19)</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC AND DILUTED</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21,753,001 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20,833,671 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21,454,341 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style=" border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20,095,174 </p></td>
</tr>
<tr style="height:9pt;">
<td valign="bottom"  BGCOLOR="#FFFFFF">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:6.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU5"></a><font style="font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About</font><font style="font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-style:italic;">Jelmyto</font><font style="font-style:italic;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10.5pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;">Jelmyto<font style="font-style:normal;"> (mitomycin) for pyelocalyceal solution, is a drug formulation of mitomycin indicated for the treatment of adult patients with low-grade upper tract urothelial cancer (LG-UTUC). Utilizing the RTGel&#8482; technology platform, UroGen&#8217;s proprietary sustained release, hydrogel-based formulation, </font>Jelmyto<font style="font-style:normal;"> is designed to enable longer exposure of urinary tract tissue to mitomycin, thereby enabling the treatment of tumors by non-surgical means. </font>Jelmyto<font style="font-style:normal;"> is delivered to patients using standard ureteral catheters or nephrostomy tube. The U.S. FDA previously granted Orphan Drug, Fast Track, and Breakthrough Therapy Designations to Jelmyto for the treatment of LG-UTUC. On April 15, 2020, the FDA approved </font>Jelmyto<font style="font-style:normal;">, making it the first drug approved for the treatment of LG-UTUC in adult patients.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About Upper Tract Urothelial Cancer (UTUC)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Urothelial cancer is the ninth most common cancer globally and the eighth most lethal neoplasm in men in the U.S. Between five percent and ten percent of primary urothelial cancers originate in the ureter or renal pelvis and are collectively referred to as upper tract urothelial cancers (UTUC). In the U.S., there are approximately 6,000 - 7,000 new or recurrent low-grade UTUC patients annually. Most cases are diagnosed in patients over 70 years old, and these older patients often face comorbidities. There are limited treatment options for UTUC, with the most common being endoscopic surgery or nephroureterectomy (removal of the entire kidney and ureter). These treatments can lead to a high rate of recurrence and relapse.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About UGN-102</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UGN-102 (mitomycin) for intravesical solution is an investigational drug formulation of mitomycin in Phase 2b development for the treatment of low-grade intermediate risk non-muscle invasive bladder cancer. Utilizing the RTGel Technology Platform, UroGen&#8217;s proprietary sustained release, hydrogel-based formulation, UGN-102 is designed to enable longer exposure of bladder tissue to mitomycin, thereby enabling the treatment of tumors by non-surgical means. UGN-102 is delivered to patients using a standard urinary catheter. The Company completed enrollment in the Phase 2b OPTIMA II trial in September 2019 and intends to advance the program to a pivotal study to further investigate UGN-102 in the treatment of this condition.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">About the Phase 2b OPTIMA II Trial</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">OPTIMA II (OPTimized Instillation of Mitomycin for Bladder Cancer Treatment) is an open-label, single-arm, multi-center Phase 2b clinical trial of investigational agent UGN-102 (mitomycin) for intravesical solution to evaluate its safety and efficacy in patients with low-grade non-muscle invasive bladder (LG NMIBC) cancer at intermediate risk of recurrence. Intermediate risk is defined as one or two of the following: multiple tumors, solitary tumor &gt;3 cm, or recurrence (&#8805; 1 occurrence of LG NMIBC within one year of the current diagnosis).</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;">About&#160;UroGen Pharma Ltd.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UroGen is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options. UroGen has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen&#8217;s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen&#8217;s approved product, Jelmyto (mitomycin) for pyelocalyceal solution, and investigational treatment UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade non-muscle invasive bladder cancer, respectively. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com to learn more or follow us on Twitter, @UroGenPharma.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU6"></a><font style="font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">COVID-19 Pandemic Potential Impact</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">UroGen continues to gather information in this very fluid and rapidly-evolving environment regarding the potential impact of the COVID-19 pandemic on our Company, however, we are not currently able to quantify or predict with any certainty the overall scope of impact on UroGen, its research and product development plans, or its commercialization plans for <font style="font-style:italic;">Jelmyto</font>. Our primary focus is on the health and well-being of patients, caregivers, and UroGen employees at this critical juncture.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Forward Looking Statements</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation: the potential of UroGen&#8217;s proprietary RTGel technology platform to improve therapeutic profiles of existing drugs; UroGen&#8217;s plans to secure coding and reimbursement for <font style="font-style:italic;">Jelmyto</font>; the potential of UGN-102 for LG NMIBC; the potential initiation of a pivotal Phase 3 study of UGN-102 in LG-NMIBC by the end of 2020; the potential of UGN-102 to provide a non-surgical treatment alternative for approximately 80,000 patients diagnosed with LG-IR-NMIBC in the United States; and financial guidance for 2020. These statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to: the timing and success of clinical trials and potential safety and other complications thereof; the ability to obtain regulatory approval within the timeframe expected, or at all; the ability to maintain regulatory approval; complications associated with commercialization activities, including complications resulting from the ongoing COVID-19 pandemic; the labeling for any approved product; the scope, progress and expansion of developing and commercializing UroGen&#8217;s product candidates; the size and growth of the market(s) therefor and the rate and degree of market acceptance thereof vis-&#224;-vis alternative therapies; UroGen&#8217;s ability to attract or retain key management, members of the board of directors and personnel; and any negative effects on UroGen&#8217;s business, commercialization and product development plans caused by or associated with COVID-19. In light of these risks and uncertainties, and other risks and uncertainties that are described in the Risk Factors section of UroGen&#8217;s Form 10-Q filed with the SEC on August 10, 2020, and other filings that UroGen makes with the SEC from time to time (which are available at http://www.sec.gov), the events and circumstances discussed in such forward-looking statements may not occur, and UroGen&#8217;s actual results could differ materially and adversely from those anticipated or implied thereby. Any forward-looking statements speak only as of the date of this press release and are based on information available to UroGen as of the date of this release.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">INVESTOR CONTACT:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Peter Pfreundschuh</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Chief Financial Officer</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;text-decoration:underline;">Peter.Pfreundschuh@urogen.com</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">646-768-9531</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10.5pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">MEDIA CONTACT:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Eric Van Zanten</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Senior Director, Communications</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;text-decoration:underline;">Eric.VanZanten@urogen.com</font><font style="Background-color:#FFFFFF;"> </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">610-529-6219</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10.5pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Source: UroGen Pharma Ltd.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10.5pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gavzukk22krh000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gavzukk22krh000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &'!#\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M117E'LA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P">S_ =\(?COXM^"VJ?:-!O2UC(V;C2[DE[:?W*Y^5O]I<'CJ1Q7Z)? _\
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MPV+P^,A[3#S4EY,****YCK"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP_\ ^#2#_P"+KHCAZTUS1@VO1G'/&X6G)PG5BFNC:.JHKE?^%L>"/^AQ\/\
M_@T@_P#BZUM$\3:/XFADET?5K'5HXVVN]C<I,$)Y )4G!I3P]:FN:<&EYICI
MXS#5I<E.I%OLFF:E%%<EXB^+'@[PK(T6J^)-/M9U.&@$P>5?JBY8?E4TZ-2M
M+EI1<GY*Y=?$4<+'GKS45W;27XG6T5Y7_P -0?#+./\ A)?_ "0NO_C5;NA_
M&SP+XDF6*Q\4:>\K$!8YI/)9B>@ <*2?I79/+<;37-.A-+SB_P#(\ZEG65UI
M<E+%4Y/LIQ;_ #.WHIJL&4$'((R"*=7G'LA1110 457OK^VTRV>XO+B*UMTY
M:6:0(H^I)Q7#:K\?OA[HS%;CQ78N1_SZEKC]8PU=-'#5\0[4:;EZ)O\ (XL1
MCL+@U?$U8P_Q22_-GH-%>5_\-0_#'_H9O_)"Z_\ C5;NC_&SP)KL@2T\5::7
M/ 2>80D^P#XS^%=$\MQU-<TZ$TO.+_R..GG65UI<E+%4Y/RG%_J=O13(I4FC
M62-UDC895E.01Z@T^O./9W"BBB@ ILC"-2S$*JC)). !3J\K_:A\7OX)^!'B
MZ_A?;<S6OV*+'7=,PB)'N%<M_P !K?#T98BM"C'>32^]G-B:\<+0G7EM%-_<
MKGYW?M!_%27XO?%+6-<$C-IRO]ET]">$MD)"''8MRY'JYKSFBBOZ+HT88>E&
MC35E%61_+N(KSQ-65:J[RD[OYA6CX=\.ZGXMUJTTC1K*;4-2NW\N"W@7+.>O
MX  $DG@ $FLTU^BO[$OP3M/ _P /[?Q?>P!]?UZ'S8Y&',%H>8T7_? #D]\J
M.W/EYMF<,KPSK-7D]$O/_(]?)<IGG&*5!.T5K)]E_F^AQ_PM_P""?>G6]I!>
M^/=5FNKQ@&;2],?9$G^R\I&YO?;MYZ$CD^VV/[*7PFTZ$11^"K%U]9Y)96_-
MW)KUJBOQK$9SC\5)RG6:\D[+[D?NV%R'+<)!0IT8OS:N_O9X-XG_ &)OA5XA
MMW6WT:XT*=O^7C3;R0$?\!D+I_X[7R;\=_V/?$GPBLY]:TV;_A(_#4?S2W,4
M>V>U7UE0$_+_ +:DCN0M?I74<T27$;Q2HLD;J59&&0P/!!'<5V8'B''8.:<I
MN<>JD[_<]T<.8<,Y=CJ;4::IRZ.*M]Z6C_K4_%BBO;?VM/@K%\'/B2W]FPM%
MX=UA6N[%>T)!Q)"#WVD@C_9=>IR:\1%?M.%Q%/%T8UZ3]V2O_7H?@F+PM3!5
MYX>LO>B[?UZ[BU^@O[!_Q;;Q9X'NO!VH3F34=!PUL6/+VC'@?\ ;*_1D':OS
MZKUC]EGQT_@'XY>&;LR%+2]G_LVY&< QS80$^RN4;_@%>5GN"6.P$X6]Z.J]
M5_GL>SP[F#R_,:<[^[)\LO1_Y/4_5.BBBOP8_HX**** "BBLS7?$VD>%[476
MLZK9:1;=/.OKA(4_-B!347)VBKLF4E!<TG9&G17D6J?M9?"71Y"D_C2TD(./
M]%@FN!W[QHP[53A_;(^#T\BHOC%0S'&7TZ[4?F8L"O066XZ2NJ$[?X7_ )'F
M/-LOB[/$0O\ XH_YGM-%<3X9^-7@+QE(D>C>+M(O9WY6W%TJ2GZ(Q#?I7;5Q
MU*52B^6I%I^:L>A3K4ZT>:E)27D[A11161J%%%% !16;KWB/2?"VGF_UK5+/
M2+%6"&YO[A((PQZ#<Q R?2N;_P"%W_#G_H?_  O_ .#FV_\ BZVA1JU%>$6U
MY(PGB*--\LYI/S:.VHKB?^%X?#G_ *'_ ,+_ /@YMO\ XNKVA_%#P;XFU*/3
M]'\6Z%JU_("4M;'4H9I6 &20JL2< $]*J6'K15W!V]&1'%8>348U$V_-'444
M5SGBSXB^%O L>_Q#XATW1LC*I>7*1NW^ZI.YOP!K*$)5)<L%=^1M4J0I1YZC
M27GH='17C%S^V+\'[69HG\8QLPZF*PNW7\&6(@_G5_1?VJOA/KTRQ6WC:PB9
MC@&]22U7\3*J@5VO+L;%<SH3M_A?^1Y\<UR^3Y8XB#?^*/\ F>L455TW5+/6
M;..[T^[@OK2092>VE61&'LRD@U:K@::=F>FFFKH****0PHK%\4^,]!\#Z?'?
M>(=9L=$LY)1"EQ?W"PHSD$A06(R<*QQ[&N8_X:$^&/7_ (6!X;Q_V$X?_BJZ
M(8>M47-"#:\DSGGB:%-\LYI/S:/0:*YF7XF^$88]$>3Q+I2)K>/[,9KM +W)
M4#RN?GY91Q_>%=-64H3A\2L:QJ0G=1=[!16)X=\;>'_%\E['H>M6&KO8R>5<
MK97"RF%^?E;:3@\'KZ5MTI1E!\LE9A&<:BYH.Z"BBBI+"BBB@ HHHH ****
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M^E(^\J***_G$_M,^-_VU_P#D?M#_ .P8/_1KU\[U]$?MK_\ (_:'_P!@P?\
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M].VG<_7.#N"Z>=47C\<VJ5[12T<K;MOM?335N^UM?D>;]B/5Q;[H?$]B\_\
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M[']0A7F?[2UA%J7P%\<Q3#*+IDDP'^TF'7]5%>F5YY^T/_R0OQW_ -@>Y_\
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MW[$^FU^ XG#5<)5=&O&TD?VG@,?ALSP\<5A)J4)=5^3[-=4%%%%<QZ 4444
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MX&#]Z6K]%M][_(_:?#;)YUL7/-*B]V":CYR>_P!R_,NT445^0']&'QO^VO\
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MX/!KGSG*XYKA_9WM):I_IZ,Z<BSB63XKVMKPEI)>7=>:_P" ?LC17QU\._\
M@H7I=Q:0V_C70;BTNU7:]]I.)(G/]XQL0R?@6KU&']M;X0R6[2GQ)-$X_P"6
M+:;<ES^49'Z]J_(:V29C0ERRHR?HKK\+G[?A^(,KQ$.>->*]7RO\;'NE1S3)
M;QO+(ZQQH"S.QP% Y))["OFOQ-^WY\.M)AD_LJVU;7;C'R".W$$9/NSD$?@I
MKY8^-7[6?C'XR0RZ;N7P_P"'G/S:98N29AZ32'!?Z *OMD5W8+AO'XJ:]I#D
MCU;_ ,M_ZW/.Q_%66X.#=.?M)=%']7M_6Q]V^ ?VDO WQ(\;ZGX6T74_-U"S
M/[F1P%BO0!\Y@;/S[><],@9&1S7J5?BYINI7>CZA;7UA<RV=[;R++#/"Y1XW
M!R&4CH0:_13]EW]JZT^+=O#X<\1-%8^,(8\(^0L>HJ!RZ#^&0#ED_%>,A>_.
MN&Y8&'M\+>4$M>Z\_3\O3;S<@XJCF$_JV,M&;?N]GY>O;OZ[_1]%%%?#'Z(?
M//[=O_) +O\ ["%M_P"A&OS:K])?V[?^2 7?_80MO_0C7YM5^R<)?\BY_P")
M_DC\)XU_Y&B_P+\V%>O?LD_\G$>#/^OB7_T1)7D->O?LD_\ )Q'@S_KXE_\
M1$E?29C_ +E6_P ,OR9\KE?^_P"'_P <?_2D?J;1117\[G]0!7GG[0__ "0O
MQW_V![G_ -%FO0Z\\_:'_P"2%^._^P/<_P#HLUV8/_>:7^)?F<.._P!TJ_X9
M?DS\EZ***_HP_EHV_ __ ".F@?\ 80M__1BU^R%?C?X'_P"1TT#_ +"%O_Z,
M6OV0K\NXS_B4/27Z'Z_P'_#Q'K'\F%%%%?G!^J!1110 4444 %%%% !1110
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M/V;M,.K?'CP- %W;=4AN.F?]6?,S_P".5^L=?E/&4O\ :*4>T7^+_P" ?LO
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M ,C1?X%^;"O7OV2?^3B/!G_7Q+_Z(DKR&O7OV2?^3B/!G_7Q+_Z(DKZ3,?\
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MBJT,/",ELU&*:Z;I!1117">H%%%% !1110 4444 87B;P-X?\91!-;T:SU/
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MZ#;^3U?Z_<?GE:K_ &3Q$IRTIXA)?]O+1?I_X$?HC1117PQ^AA1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5;4M.MM7T^ZL+V%;FSNHF@FAD&5=&!5E/L02*LT4TVG
M=":35F?D=\;?A?=_!_XD:KX<N-[V\3^;9SN,>?;N<QM[G&5/^TK#M7T]^Q'^
MT<&2V^''B2YPR_+HUW,W4=?LQ)_\<_[Y_NBO4?VQO@:?BMX!_M;2K?S/$NAJ
MTT"H/FN8.LD7N>-R^X('WJ_-B.1X)4EC=HY$(974X*D'@@^M?LF%E1XERSV=
M;XUH_*71_/\ S1^$XR%?A3-O:T%^[EJNSB]X_+_)G[4T5\V?LF_M01?%;3HO
M#/B*=8O%]G'\DSD :C&H^^H_YZ ?>7O]X=POTG7Y/C,'6P-:5"LK-?CYKR/V
MC XZAF-".(P[O%_@^S\PHHHKB.\**** "BBB@ K,\3:@^D^&]6OH_P#66MI-
M.OU5"1_*M.H+RTBO[.>VG7?#-&T;KZJ1@C\JN#2DG+8RJQE*G*,'9M.WJ?FC
M)(78LQ)8\DFHR?2ND^('@;4?AWXFNM'U&)E:-B89L86://RNI]#^AR#TKF2>
MM?TM2J0K052F[Q>J/X&KT*N%JRHUXN,XNS3Z,1C3"U+6YX*\$ZM\0-?@TG1[
M9IYY#^\DP=D*9Y=SV4?_ %AR0*J=2%*+J5'9+=E4*%3$5(T:,7*4G9);MGV=
M^S$TK?!70?,^[NN!&?\ 9\^3^N:]4K'\(^&K;P=X8TS1+0EH+&!80Y&"Y Y8
MCU)R3]:V*_G''5HXC%5:T-I2;7S=S^Y\IPL\#E^'PM3XH0C%^J23"BBBN(]4
M**** "BBB@ HHHH *^8OVROVC!\.=!D\(:!=8\3ZG%BXGB;YK&W88)SVD<<+
MW RW'RY[?]I3]HG3O@;X:V0&*]\4WJ$6-@S?<'(\Z0#H@/0?Q$8'0D?F/KFM
MWWB36+S5=3NI+W4+R5II[B4Y9W)R2?\ /'2OO.&\D>*FL9B%[BV7\S_R7XGY
MQQ5Q L'!X'#/]Y+=_P J_P W^"^11I:**_7#\3"BBM'P[X?O_%6O6&C:7 UU
MJ-],L$$*CEF8X'T'J>PR:4I**<I.R148N348J[9[S^Q/\'3\0_B4OB"_AWZ'
MX=9;@[A\LMUG,2>^""Y_W5!^]7Z0UP_P8^%MC\'OA[IGANS*R20KYMW<J,?:
M+AL;W_/ &>BJH[5W%?@V=9D\RQ<JD?@6D?3O\]S^C>'\K64X*-*7QRUEZ]OE
MM^(4445X)](%%%% !1110 5\V?M^_P#)"[?_ +#%O_Z+EKZ3KYL_;\_Y(9;_
M /88M_\ T7+7M9+_ ,C&A_B1X&?_ /(KQ'^%G%?L9?!?P1X^^$4VI^(?#=EJ
MU^-3FA$]PI+! D9"]>F2?SKWC_AF'X5_]"1I?_?#?XUYY^P'_P D+G_[#%Q_
MZ!%7TG79G&,Q-/,*T859)*3ZLX<CP.$J990G.E%MQ6KBO\CR[_AF'X5_]"1I
M?_?#?XUR?C#]B/X7^)K21;'3+CP[>,#MN=.N7(![91RRD>P ^M>^T5Y=/,L;
M3ES1K2^]GKU,IR^K'DG0C;_"C\Q_%WA'Q[^QK\2K6]T^^9K:8YMK^-2+;4(@
M06BE3/7IE2<C((/0U^A'PG^)6G_%KP'I?B?35\J.[3$MNS!F@F4X>,GV/0\9
M!!QS7$_M>>#K;QA\!?$9F13<:7&-2MI".4>,Y;'U0NO_  *O%/\ @G/XFF>V
M\9>'I'S!&\%_"F>C,&20_CMB_*OJ<9-9QE3QTU:K2=FUU6G^?YGQ^!IRR+.5
MEU.3=&JFXI_9>O\ E\[J^Q]4?%3_ ))AXO\ ^P/>?^B'KXW_ ."<_P#R.GB_
M_L'Q?^C*^R/BI_R3#Q?_ -@>\_\ 1#U\;_\ !.?_ )'3Q?\ ]@^+_P!&5S9;
M_P B;&?]N_F=>:_\CW ?]O?D?>-%%%?&GW84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSXV:3&+F]\+645NJ^83=:/<HA4\ D[QQ[YK[@\(>"=!\ Z/'I?A[2K72;&,
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MCR?,HYM@XXE*SV:[-?U<Q/&7C+1OA_X=N]<U^_CT[3+5<R329.3V50.68G@
M#)KX\\:_\%#[^;4&M_!GA:W\C?MCN-89I'EYX_=1LNWZ;S7M?[4O[/=_\==
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2G'E;J.Z[/73Y!1117Q!^@A1110 4444 %%%% !1110 4444 %%%% !1110
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M0 *J@8  ["I***_/S],"BBB@ HHHH **** "BBB@ HHHH *^;/V_/^2&6_\
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MQF)FJ=.D[OR=OFS['$YM@<)3=2K6C9>:;^2W9\X^,M2CU3]NBWGC*LJ^+[&
M[>F8YX8S^J&OTFK\F/A>=2?]H+P7+K"SIJ=QXCL+B?[2A61FDN8WW$'^]N#?
MCFOUGKZCBFFJ+PU)._+"WW'R/!]5UUBZS5N:=_OU"BBBOA3]$"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *HZQHNG^(=-GT_5+*WU&QG&V6VNHEDC<>A5@
M0:O44TW%W6XFE)6:T/DWXK?L!^'_ ! TU]X)U!O#MXWS?V?=;I;1C[-R\?\
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MY<WL%][_ "O8\I^'W[-'@7X9:/?6FB:?)]MO;=[:;5;MQ+=%74J<,1M3@]%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
@ !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>urgn-20200810.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-08-06T00:30:25.0593379+00:00 -->
<!-- Version            : 5.0.1.476 -->
<!-- Package ID         : 05e185b275f2409eaf0cd869d4d8b0c0 -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:urgn="http://www.urogen.com/20200810" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.urogen.com/20200810" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.urogen.com/20200810/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="urgn-20200810_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="urgn-20200810_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>urgn-20200810_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-08-06T00:30:25.0593379+00:00 -->
<!-- Version            : 5.0.1.476 -->
<!-- Package ID         : 05e185b275f2409eaf0cd869d4d8b0c0 -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>urgn-20200810_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2020-08-06T00:30:25.0593379+00:00 -->
<!-- Version            : 5.0.1.476 -->
<!-- Package ID         : 05e185b275f2409eaf0cd869d4d8b0c0 -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.urogen.com/20200810/role/TemplateLink" xlink:href="urgn-20200810.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="urgn-20200810.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>urgn-8k_20200810_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="urgn-20200810.xsd" xlink:type="simple"/>
    <context id="C_0001668243_20200810_20200810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001668243</identifier>
        </entity>
        <period>
            <startDate>2020-08-10</startDate>
            <endDate>2020-08-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001668243_20200810_20200810" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001668243_20200810_20200810" id="F_000004">0001668243</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001668243_20200810_20200810" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001668243_20200810_20200810" id="F_000002">2020-08-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001668243_20200810_20200810" id="F_000003">UROGEN PHARMA LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001668243_20200810_20200810" id="F_000007">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001668243_20200810_20200810" id="F_000006">001-38079</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001668243_20200810_20200810" id="F_000008">98-1460746</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001668243_20200810_20200810" id="F_000009">400 Alexander Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001668243_20200810_20200810" id="F_000010">4th&#160;Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001668243_20200810_20200810" id="F_000011">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001668243_20200810_20200810" id="F_000012">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001668243_20200810_20200810" id="F_000013">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001668243_20200810_20200810" id="F_000014">+1 (646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001668243_20200810_20200810" id="F_000015">768-9780</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001668243_20200810_20200810" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001668243_20200810_20200810" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001668243_20200810_20200810" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001668243_20200810_20200810" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001668243_20200810_20200810" id="F_000020">Ordinary Shares, par value NIS0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001668243_20200810_20200810" id="F_000021">URGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001668243_20200810_20200810" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001668243_20200810_20200810" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139955511637928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 10, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 10,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UROGEN PHARMA LTD.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001668243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1460746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">400 Alexander Park Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">4th&#160;Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+1 (646)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">768-9780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Ordinary Shares, par value NIS0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">URGN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " "9.@I1)!Z;HJT
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M2P$"% ,4    " "9.@I1!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )DZ"E'*Z^Z![@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M )DZ"E&97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ F3H*48&;Y,%B!   ^!   !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M )DZ"E&#J:4#U $  #(&   -              "  :4,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ F3H*49>*NQS     $P(   L              ( !
MI X  %]R96QS+RYR96QS4$L! A0#%     @ F3H*41PX9>H_ 0  / (   \
M             ( !C0\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( )DZ
M"E$D'INBK0   /@!   :              "  ?D0  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( )DZ"E%ED'F2&0$  ,\#   3
M          "  =X1  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  "@3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="urgn-8k_20200810.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="urgn-8k_20200810.htm">urgn-8k_20200810.htm</File>
    <File>urgn-20200810.xsd</File>
    <File>urgn-20200810_lab.xml</File>
    <File>urgn-20200810_pre.xml</File>
    <File>urgn-ex991_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "urgn-8k_20200810.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "urgn-8k_20200810.htm"
     ]
    },
    "labelLink": {
     "local": [
      "urgn-20200810_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "urgn-20200810_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "urgn-20200810.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "urgn",
   "nsuri": "http://www.urogen.com/20200810",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "urgn-8k_20200810.htm",
      "contextRef": "C_0001668243_20200810_20200810",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "urgn-8k_20200810.htm",
      "contextRef": "C_0001668243_20200810_20200810",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.urogen.com/20200810/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-20-038598-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-20-038598-xbrl.zip
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M?@T>V\LWQ;,_ +0-$S=_V!7<3"*G!<KN]-+R5NK=?GDSZYTF]^(;&5X33^/
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M62T13T"I#M3T-4O8UFG7/M/;)^QEN%MGUSOU>EQNE:_%]0]02P,$%     @
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M\S*CW20.E+:@,B.6MB.TM$7 [H[V910< U8=&]GA]N_W.! ")9G"=#-:*3Q
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M9FG/9N?OYHKY,KMA/_X+4$L#!!0    ( )DZ"E%,EOS0&A$  *.]   4
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M,+_$RES84H;HZ[2[E/B'2-?O/%!0Y_^YO_+&R:E1JU92XTFRP?S=9T61-#%
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MC0_B@Y)T*1W0#WC^?LHE T2>RO"/9)U] 'WW1A/0YD.MS1.@$W ?)I;@,U_
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MDUDMG#8N61,NB<!E*"BH "B_("USV]__'1>PIE,_TSWIYDZVAW>GB<Q^'$+
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M;FO.O53>)3(17(CD0!EUN/PC=Y-=#T$=6;$/O@K0A^<K!7G4UL[4&RH@@I$
M]041#63X3?E+HSBT'+PXYB%R7]_A-BJKIII'O4[6F[F;UVMP-U,$EW8CTSJO
MQ8%<J,W3CB&?=PVU5YMZAMH)//-&/G<G2%,^&"0H1+@!F !5B\1B3+OUZKK7
MNFRP5@MJBL0/U[O"C\2H#\TL%LRZ8A7L4==63B"WQ]AAJA2 'GI\I%G)EV,O
M0HF+8GN"7]W& 4(R)W-BUD;W$72&T'++<Y&B/9<8;&D&>Z)#>UA^]FAMUH /
M\"<8YS]!@ELN2) SXZC+*4<A%WU.U#)Q1GNI5!TFK.?YPLTYO"\<@Z$..2+'
MD4F "2*90X\+GIHB:('R*KW4&@%ON\^:?( B^S+^15X!ZQ\KMPV4.>2W(M)V
M7]S>PKW69,'-N1>\/\>@$+JS]F7K\]EAZJ3RZ!$27G 6T*6[?X,BGEM%G^ 9
M0A>A)Q/=>:G'<@LDXMT!?B<:.6"7A-(,;*=4%*R^8+\,HM,2LP#C.1<06.,#
MT':M4#EE)O.LZ;<J4M--4.T&'/#MZ.&E[TZ=R,0GE.%A9@EB>76:XY"W$(0>
M/])F$\4<KK&+R%X)@.\>KF$;5*:L+SU?M<42L<HP*H.'AL\6:98,E*X?2\=&
MN^E"X##31XSR>*0-$ M]84%UH\DT[M'N.'H>X-?;,A0J*.D+B\= $E,E!:]!
M!*B)(E(!F X<\HF+PH!14K\)*J-=F@ ^!Z'(H6F$1DW]$P--Z(M<F30!-Y^4
M4XW"URKS[$489""3>4R.5*)$>2G<5Y#A^VZE(S!. C=' L4!3N@23ILP];(>
M5&?^K4O[3SI8?2(5IWL- 9SF>U2>-*GR! %*6P31)M",0.K4D>V#\.U!"Z:9
M(OAEQU9D3/-9RR9HM2>T: IFKWV1.3!T@#L'&D"&1/R<BZCC7"\56A0DN(0B
MH'KP,1/Q(*0WX)KEQ+9&=[G4,+YV.4N4OB,0J%(ZXS#5!I"2(<2P_XEY$"G?
M%L,+$ 9+1 A(^W=M\T!7@B3G"#>TPH +)\_^D*&,V-W=73Y&'7#SH.R(!<AB
MX&I9 *RUA0)'&>P'ZT%Q$=;FOW4%-/.MW6R\9427QD9I;'1M8Z/5;1@;/;OZ
MHW6>@[#R&EA%C, (74^M5 O,MQ6M<D!P$\X)1+!@1V.AHN4!3T)@?%I'+RKT
M!2X<8ZKPUHFEK1-WW)>V,\F)L>>,=6)Q+ //5;8E$ .(]].<PLRN2X58:EFG
MV/HIMA@LQ4&:$0 /PKM#JV&P.YW[=+TH]:PQHXU6&RH-# W%WZI$IA^@68XT
M-:NL@@C0$8@FZI6>LD%@URR@;14J)35R$]8W5+ #]@!XVAJJEB;V=R&C!+X,
MFGTTEYCN]$8C$:!+)O_4H*GKRIR^<"@[SZ[B8)I,O_4LL U2F0>L/M@C)]*U
MNA,..%8JI8O9]\3#,\"D ?B8C FU Y#TLACYCC<1F*F.DLQ%(+4;^N_8M2)P
M>+8A0/G,K6^#P(M=.V>!KQ:<)#/H7D?V[TD4OWG!'>:X+CQ/N8+="-PCE0U?
M:Q/?ES)Z*#B@8F$X=:N1/D"_E+ C #DG 2"< L!X&KU "#$?M:?)O4".T9?L
M8MRMQCO8A4Q]5M81*FAH:-XPZ_7*G$^HASHPJ:2&1=03)_=(!YYZ)@6KHYQ'
MY@F\/ @Y?? >Q0)03H@M0ZP4)^IQ#SGJQQ!831/4+R2*TT=:F7CT6%J:G[A_
MFW0!V6E::I8%U=FD4I(-G2L,^NCB2T[G.OJ39"3(QCMPK/R96F F&,"3X(+S
MQ>!@%H, FXD 1^S'0M5Z<7RN5E #<[/H=3J^IM@=JM7J)#5+1RQ=-32F= ^Z
M X$&20,G'^LV -.E4L'X)JQ\.G U+ZG02V'<_[? 4 ^SQ&ZL,LN8BY+A-^#4
MV$TM"LJI&K*$B'#D)X'@G&3V02K18$T'[#PMF1%\3J0@C"T+E0F*7\SBZ9)G
MN,YEWSQEH56R/(T_=2K?N]6]P?O2D9%*:7M]K"F:8QQ#\$#<=50))29YJZ1"
MXC8 GPQC7VBYL)5EX]@_SH,R1]CV)TH]O5<O@,:SI$IMJ"Y[:"@Y1EU*Y^<C
MO<52@&\P?0??WP881:$==P<>?O' A=#55;E3]0"VPYT\"*;U;<H+,/2P ':#
M2FY^AZ+"1#\2DY]VUWSU\;N'M*(<!8@J;1 U)8+J-<#1ZGF@_3N,&+7[ ^S^
M340?PD/=?;JJ>HQ>#9;B!UM S92CHN\&O"SA1^F(!G8Z&\LP]\M/Q6+Y-*=&
MT>=T2O.6% ^I::Y#>:0#:97Y5#W[34S@?2YXXZ@5!D3SJ 1A6O&^AX8.X9%J
ML#C)/T$<''JN*QRM> B[*P:Z(CKO$<[\K&E%^CA*!. ;CPG'<]X74[DM&TD)
MD;LG::E@J*D #AK I/:A3AXG*;-Y93;FU.N)6[092U(AX$#U9T:L@QGIW[B&
M(\1D@A:A>\W]#2V+6<C]#T,C8L]&ZKO-,T2G$0_B,(([TKE(LSK! R!T21T2
MMV[$OXEPL1"M(Z#2*O6"OS_<#27ZLCB!8,REH_QFS+M%D7]R=(1)"JAP?N"-
M#_7<)X!:3W0 D9>!%8]")7'(P"$XI,D,!R"OX7-6?\0GBO]4XGS>&9T)(?B=
MW$GT&]WHV &1ER K 4,;$,CIS!5NJS0D?$HX .P 0[??DK[J=73%D32$G0YL
MYEG#G3Q7P="'4!- QU=,A=M.YBE$#UV=='Z*3F>JT&@6)LV0!=B3WGFBU*2\
M^_[V:AW#K7+$=WU<L]7^H]GM776 =MJ]QEGO)'O9@ 7W\\G>/_ATK:9N7=\&
M JZ&UC >9C8!LFR3SX92W++?IH[D%8Y_BF#'VZT*M(7EZ>SV28PY.DS"ID*0
MGQ>"_YZEN7<<EX-/U7(U=URMY>J5DOF^\W(S3)&7S?-68P_XL1E(B_W!7?:_
M.(W=W7EEZ I7@N]UGH0"!B9O1[&;!F\[WO[G2!(E(0^2H 7A$8)<$F&VXQ@"
MH4) 5"G6<]6B6<_X0H?M!+CKQ8$E3MAC<VHR#?=JWKD/P]@?C_J>/<'1[*-A
M-'+@C_\#4$L! A0#%     @ F3H*4;#\4L>S!   M18  !$
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M2P$"% ,4    " "9.@I1LOM8 .0L  "0T0( $               @ '"(@
F=7)G;BUE>#DY,5\V+FAT;5!+!08     !0 % $4!  #43P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
